Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical implications of p53 mutations.

R R Wallace-Brodeur1, S W Lowe

  • 1Cold Spring Harbor Laboratory, New York 11724, USA.

Cellular and Molecular Life Sciences : CMLS
|March 5, 1999
PubMed
Summary

Understanding the p53 tumor suppressor gene

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A common functional consequence of tumor-derived mutations within c-MYC.

Oncogene·2014
Same author

Granule exocytosis mediates immune surveillance of senescent cells.

Oncogene·2012
Same author

The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.

Oncogene·2012
Same author

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A.

Leukemia·2011
Same author

Transgenic, inducible RNAi in megakaryocytes and platelets in mice.

Journal of thrombosis and haemostasis : JTH·2010
Same author

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.

Oncogene·2010

Area of Science:

  • Oncology and Molecular Biology

Background:

  • The p53 tumor suppressor plays a critical role in cancer biology.
  • Mutations in p53 are common in many human cancers and are linked to tumor progression.

Purpose of the Study:

  • To explore the utility of p53 knowledge in cancer diagnosis and prognosis.
  • To identify new therapeutic strategies based on p53 biology.
  • To address challenges in translating basic cancer research findings to clinical applications.

Main Methods:

  • Analysis of p53 tumor suppressor biology.
  • Correlation of p53 mutations with clinical tumor behavior.
  • Evaluation of conceptual and technical limitations in translational cancer research.

Main Results:

  • p53 information is valuable for cancer diagnosis and prognosis.
  • p53 insights may lead to novel therapeutic approaches.
  • Translating basic cancer biology to the clinic faces significant hurdles.

Conclusions:

  • Lessons learned from p53 research can guide future efforts in cancer therapy.
  • Integrating cancer gene function, genetics, and therapy is crucial for progress.
  • Further research is needed to overcome translational barriers in oncology.

Related Experiment Videos